Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.22.1
Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:    
Research and development $ 3,459,340 $ 1,607,819
General and administrative 4,397,524 1,565,034
Total operating expenses 7,856,864 3,172,853
Loss from operations (7,856,864) (3,172,853)
Other income and expenses:    
Gain from forgiveness of Paycheck Protection Plan loan 0 (133,592)
Interest expense, net 45,613 197,269
Net loss (7,902,477) (3,236,530)
Deemed dividend upon the redemption of 5,221,156 shares of Series 1c preferred stock (see Note 6) 269,038 0
Deemed dividend upon the amendment of terms of the Series 1d convertible preferred stock (see Note 6) 2,293,199 0
Net loss attributable to common stockholders $ (10,464,714) $ (3,236,530)
Net loss per share of common stock, basic and diluted $ (2.43) $ (1.69)
Weighted-average basic and diluted common units/shares 4,302,232 1,911,009